A comprehensive view of biopharmaceuticals / biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Regeneron partners with CRISPR drug developer Mammoth Biosciences to develop in vivo gene therapies; the US$100.0M deal combines Regeneron's viral vector technology with Mammoth's DNA editing platforms for 5.5 years, with option to extend
Published: April 25, 2024 by BioPharma Dive
Executive Perspective: AstraZeneca CEO Pascal Soriot defends recent spate of acquisitions, arguing they're vital for future growth; Soriot says the deals aim to create synergy between oncology, vaccines, and respiratory disease products
Published: April 25, 2024 by FiercePharma
Merck's newly approved PAH treatment, Winrevair, forecast to reach sales of US$3.9B by 2029; the robust start to the drug's launch signals a significant boost for the company's future revenue with cancer drug Keytruda's patent expiry looming
Published: April 25, 2024 by FiercePharma
Executive Perspective: Moderna CEO says new partnership with OpenAI to play key role as the company works to develop new mRNA medicines; goal is to have employees use ChatGPT no less than 20 times a day
Published: April 25, 2024 by Gizmodo
Bristol Myers reports Q1 US revenues up 7% year-over-year to US$8.5B primarily due to Eliquis, Reblozyl and Opdualag; International revenues remain flat at US$3.4B primarily due to lower average net selling prices
Published: April 25, 2024 by Business Wire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count